Chronic Pain in Canada--prevalence, Treatment, Impact and the Role of Opioid Analgesia

作者: Dwight E Moulin , Alexander J Clark , Mark Speechley , Patricia K Morley-Forster

DOI: 10.1155/2002/323085

关键词:

摘要: OBJECTIVE: To assess the prevalence, treatment and impact of chronic pain in Canada.METHODS: A stratified random sample 2012 adult Canadians (weighted by sex, age region according to 1996 census data) was surveyed telephone 2001 determine prevalence pain, defined as continuous or intermittent for at least six months. second 340 sufferers who were taking prescription medication their studied detail current therapeutic approaches social economic pain.RESULTS: Chronic noncancer reported 29% respondents, with increased frequency women older groups. The average duration 10.7 years intensity 6.3 (on a scale from 1 10), 80% reporting moderate severe pain. Anti-inflammatory agents prescribed 49% respondents opioid analgesics 22% (two-thirds these codeine). Almost 70% worried about addiction potential, one-third felt that strong should be reserved terminal illnesses. one-half unable attend family events, mean number days absent work past year due 9.3.INTERPRETATION: is common Canadian adults has major impact. Despite growing evidence supporting efficacy safety less than 10% patients treated opioid. undertreated Canada, are probably underutilized management part multidisciplinary program.

参考文章(24)
Andrew C Darke, John H Stewart, Efficacy and abuse potential of opioid analgesics and the treatment of chronic noncancer pain Pain Research & Management. ,vol. 4, pp. 104- 109 ,(1999) , 10.1155/1999/352469
Roman D Jovey, Jeffrey Ennis, Jacqueline Gardner-Nix, Brian Goldman, Helen Hays, Mary Lynch, Dwight Moulin, Use of opioid analgesics for the treatment of chronic noncancer pain - A consensus statement and guidelines from the Canadian Pain Society, 2002 Pain Research & Management. ,vol. 8, pp. 197- 208 ,(2003) , 10.1155/2003/436716
D.E Moulin, R Amireh, W.K.J Sharpe, D Boyd, H Merskey, A Iezzi, Randomised trial of oral morphine for chronic non-cancer pain The Lancet. ,vol. 347, pp. 143- 147 ,(1996) , 10.1016/S0140-6736(96)90339-6
Joan Crook, Elizabeth Rideout, Gina Browne, The prevalence of pain complaints in a general population Pain. ,vol. 18, pp. 299- 314 ,(1984) , 10.1016/0304-3959(84)90824-8
Fiona M. Blyth, Lyn M. March, Alan J.M. Brnabic, Louisa R. Jorm, Margaret Williamson, Michael J. Cousins, Chronic pain in Australia: a prevalence study Pain. ,vol. 89, pp. 127- 134 ,(2001) , 10.1016/S0304-3959(00)00355-9
Robert N. Jamison, Stephen A. Raymond, Ellen A. Slawsby, Srdjan S. Nedeljkovic, Nathaniel P. Katz, Opioid Therapy for Chronic Noncancer Back Pain Spine. ,vol. 23, pp. 2591- 2600 ,(1998) , 10.1097/00007632-199812010-00014
Keith Milligan, Michel Lanteri-Minet, Klaus Borchert, Henk Helmers, Royden Donald, Hans-Georg Kress, Hugo Adriaensen, Dwight Moulin, Voitto Järvimäki, Ludo Haazen, Evaluation of long-term efficacy and safety of transdermal fentanyl in the treatment of chronic noncancer pain. The Journal of Pain. ,vol. 2, pp. 197- 204 ,(2001) , 10.1054/JPAI.2001.25352
Y. Harati, C. Gooch, M. Swenson, S. Edelman, D. Greene, P. Raskin, P. Donofrio, D. Cornblath, R. Sachdeo, C. O. Siu, M. Kamin, Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy Neurology. ,vol. 50, pp. 1842- 1846 ,(1998) , 10.1212/WNL.50.6.1842
Sandra E. Ward, Debra Gordon, Application of the American Pain Society quality assurance standards. Pain. ,vol. 56, pp. 299- 306 ,(1994) , 10.1016/0304-3959(94)90168-6
Ingrid Waldron, Sex differences in illness incidence, prognosis and mortality: Issues and evidence Social Science & Medicine. ,vol. 17, pp. 1107- 1123 ,(1983) , 10.1016/0277-9536(83)90004-7